Upload
kws-group
View
823
Download
2
Embed Size (px)
Citation preview
Investor Presentation
KWS SAAT SE | October 2015
Business performance of the KWS Group
Plant breeding & seed business Fundamentals
Source: DBV
48%
usable harvest
Source: FAO
42% pre-
harvest losses
10% post-
harvest losses
R&D intensity of approx. 15% of consolidated net sales
1% to 2% progress in yields and
development of tolerances and resistances
Per capita cropland (in ha)
2000 1950 2050
0.5 0.3
0.2
Harvest losses (worldwide)
Climate change
October 2015 Investor Presentation 3
°C
Global importance of agricultural crops
217
177 163
107
49 38 34
25 26 19
6 5
704
883
722
261
134
54 62 40
138
374
13 38
Source: faostat.fao.org, May 2013 *Raw sugar value, source: zuckerverbaende.de, May 2013
Acreage 2012 (in mn ha)
World production 2012 (in mn tonnes)
not part of the KWS product portfolio Trend compared to previous year
Wheat
Corn
Barley
Sorghum
Rapeseed
Sunflower
Potato
Rye
Sugar-
beet
Catch
crops
October 2015 Investor Presentation 4
TOP 6 Global agricultural seed companies Sales of agricultural crops
October 2015
Global sales in € bn
1.19 USD/EUR
1 Sales 2013/2014 „Seeds & Genomics“ w/o vegetables; FY: September 1 to August 31 2 Sales 2014, „Seeds“; FY: January 1 to December 31 3 Sales 2014 w/o flowers & vegetables; FY: January 1 to December 31 4 Sales 2014/2015; FY: July 1 to June 30 5 Sales 2014; „Seeds, Traits & Oils“; FY: January 1 to December 31 6 Sales 2014/2015; „Field seeds“; FY: July 1 to June 30
Sales* in Europe in € bn
1.19 USD/EUR
DuPont/Pioneer
Syngenta
Vilmorin
Dow
Monsanto
* Estimated sales for calendar year 2014 * Source: Phillips McDougall Consultants; own estimates KWS
Investor Presentation 5
At the beginning of fiscal year 2014/2015 we changed the presentation of the KWS Group’s consolidated financial statements due to an amendment to the International Financial
Reporting Standards (IFRS 11). We can no longer carry the net sales and costs of our 50:50 joint ventures in the statement of comprehensive income in the KWS Group. If not stated
otherwise, all figures in the following will be in accordance with our internal corporate controlling structure.
Monsanto1
DuPont/Pioneer2
Syngenta3
Dow5
Vilmorin6
4
0.9
1.3
1.3
3.2
6.1
8.3
0.1
0.6
0.6
0.7
0.7
1.0
KWS core framework
October 2015 Investor Presentation 6
Ziele
Profitable growth An average increase in consolidated net sales of 5% to 10% p. a.
EBIT margin > 10%
Research & development R&D intensity of 12% to 15% of consolidated sales
1% to 2% progress in yields p. a. for our customers and development of tolerances and resistances
Internationalization Foreign sales > 80%
Expansion of the portfolio of varieties for subtropical markets
Sustainability Integration of international subsidiaries
Dividend A dividend payout ratio of 20% to 25% of the KWS Group’s net
income for the year
The KWS Group’s medium- and long-term objectives
KWS seeds the future.
Our high-performing seeds and thorough knowledge of
agriculture make us the trusted supplier for generations
of farmers. This is our contribution in addressing
growing global food demand.
117 141 152
138 138
10/11 11/12 12/13 13/14 14/15
CAGR
4.2% 855
986
1,147 1,178 1,260
10/11 11/12 12/13 13/14 14/15
CAGR
10.2%
EBIT in € mn
EBIT margin 2014/2015: 10.9%
Sales in € mn
in € mn 2014/2015 2013/2014
Sales 986.0 923.5
EBIT 113.4 118.3
KWS Track Record
Sales and EBIT in accordance with IFRS 11 (at equity)
October 2015 Investor Presentation 7
Sales 2014/2015
Sales in € mn
714.9
351.1
107.3
4.7
1,178.0
754.4
390.5
111.3
4.2
1,260.4
Corn Sugarbeet* Cereals KWS Group Corporate
* incl. potato
Sales 2013/2014 Sales 2014/2015
October 2015 Investor Presentation 8
Total sales by region and business segment 2014/2015
October 2015
* incl. potato
Investor Presentation 9
By business segment
60% Corn
31%
Sugarbeet*
Cereals 9%
Total sales
€ 1,260.4 mn
By region
Germany 18%
41% Americas
36% Europe (w/o Germany)
Rest of world 5%
Total sales
€ 1,260.4 mn
EBIT 2014/2015
October 2015 Investor Presentation 10
EBIT in € mn
100.9
70.1
17.1
–49.7
138.4
84.2
93.0
12.0
–51.2
138.0
EBIT 2013/2014 EBIT 2014/2015
* incl. potato
Corn Sugarbeet* Cereals KWS Group
Corporate
Major EBIT drivers
October 2015 Investor Presentation 11
Major EBIT drivers in € mn
47.3
4.4
–25.2
–19.0 –2.9 138.4 138.0
EBIT 2013/2014 Gross margin Seling expenses R&D expenses Administrativeexpenses
OOI/OOE balance EBIT 2014/2015
* incl. potato
October 2015 Investor Presentation 12
Statement of comprehensive income
in € mn, if not stated otherwise 2014/2015 2013/2014 +/–
Net sales 1,260.4 1,178.0 +7.0%
Cost of sales 649.6 614.5 +5.7%
Gross profit on sales 610.8 563.5 +8.4%
Selling expenses 236.7 212.3 +11.5%
Research & development expenses 173.8 150.0 +15.9%
General and administrative expenses 80.5 76.7 +5.0%
Other operating income 89.8 60.7 +47.9%
Other operating expenses 71.6 46.8 +53.0%
Operating income (EBIT) 138.0 138.4 –0.3%
Net financial income/expenses –7.1 –12.6 –43.7%
Results of ordinary activities 130.9 125.9 +4.0%
Taxes 46.9 45.6 +2.9%
Net income for the year 84.1 80.3 +4.6%
Share of minority interests 1.3 3.2 –59.4%
Net income after shares of minority interests 82.7 77.1 +7.3%
Earnings per share (in €) 12.54 11.69 +6.8%
In accordance with our corporate controlling structure
October 2015 Investor Presentation 13
Statement of comprehensive income Reconciliation: corporate controlling structure/IFRS 11
in € mn, if not stated otherwise
Corporate
controlling structure +/–
IFRS 11
(at equity)
Net sales 1,260.4 –274.4 986.0
Cost of sales 649.6 –196.1 453.5
Gross profit on sales 610.8 –78.3 532.5
Selling expenses 236.7 –47.7 189.0
Research & development expenses 173.8 +0.8 174.6
General and administrative expenses 80.5 –5.7 74.8
Other operating income 89.8 –1.8 88.0
Other operating expenses 71.6 –2.9 68.7
Operating income (EBIT) 138.0 –24.6 113.4
Net financial income/expenses –7.1 +23.8 16.7
Results of ordinary activities 130.9 –0.8 130.1
Taxes 46.9 –0.8 46.1
Net income for the year 84.1 –0.1 84.0
Share of minority interests 1.3 +/–0 1.3
Net income after shares of minority interests 82.7 +/–0 82.7
Earnings per share (in €) 12.54 –0.01 12.53
Reconciliation 2014/2015
October 2015 Investor Presentation 14
Balance sheet - assets at June 30, 2015
in € mn 2014/2015 2013/2014
Intangible assets 85.7 73.9
Property, plant and equipment 351.9 283.9
Equity-accounted financial assets 153.0 126.1
Financial assets 2.5 2.7
Noncurrent tax assets 4.0 4.2
Deferred tax assets 54.3 47.8
Noncurrent assets 651.4 538.7
Inventories 178.0 120.2
Biological assets 12.3 12.6
Trade receivables 309.7 297.8
Securities 67.0 69.2
Cash and cash equivalents 41.2 53.1
Current tax assets 57.5 45.3
Other current financial assets 26.7 14.9
Other current assets 11.7 13.3
Current assets 704.1 626.3
Total assets 1,355.5 1,165.0
In accordance with IFRS 11 (at equity)
October 2015 Investor Presentation 15
Balance sheet – equity and liabilities at June 30, 2015
in € mn 2014/2015 2013/2014
Subscribed capital 19.8 19.8
Capital reserve 5.5 5.5
Retained earnings 705.7 604.4
Minority interest 7.7 8.1
Equity 738.7 637.8
Long-term provisions 110.6 99.0
Long-term borrowings 181.8 113.8
Trade payables 1.6 1.5
Deferred tax liabilities 28.1 26.2
Other noncurrent liabilities 12.8 12.5
Noncurrent liabilities 334.9 253.0
Short-term provisions 87.4 74.8
Short-term borrowings 32.3 40.1
Trade payables 59.7 56.8
Current tax liabilities 30.1 35.4
Other current financial liabilities 15.9 11.6
Other current liabilities 56.5 55.4
Current liabilities 281.9 274.2
Liabilities 616.8 527.2
Total equity and liabilities 1,355.5 1,165.0
In accordance with IFRS 11 (at equity)
October 2015 Investor Presentation 16
Taxes
in € mn 2014/2015 2013/2014 +/–
Results of ordinary activities 130.1 125.8 +3.5%
Expected income tax expense 37.9 36.6 +3.5%
Difference in income tax liability outside Germany 4.2 13.6 –68.8%
Tax portion for tax-free income –3.0 0.1
Tax portion for expenses not deductible for tax purposes 6.7 2.6
Tax portion for temporary differences and losses for which no deferred taxes have
been recognized
0.0 0.1
Tax credits –0.3 0.0
Taxes relating to previous years 0.3 –6.8
Other tax effects 0.3 –0.7
Reported income tax expense 46.1 45.5 +1.3%
Effective tax rate 35.4% 36.2% –2.1%
Reasons for the increase in tax rate:
strong income growth in countries with higher tax rates
special effects amongst others due to the merger of KWS MAIS GMBH with
KWS SAAT SE
In accordance with IFRS 11 (at equity)
October 2015 Investor Presentation 17
Cash flow statement
in € mn 2014/2015 2013/2014 +/–
Net income for the year 84.0 80.3 +4.6%
Cash earnings 92.1 85.0 +8.4%
Net cash from operating activities 48.1 76.1 –36.8%
Net cash from investing activities –123.8 63.1
Net cash from financing activities 48.4 –43.6
Cash and cash equivalents at end of year 108.2 122.3 –11.5%
Thereof cash and cash equivalents 67.0 69.2 –3.2%
Thereof securities 41.2 53.1 –22.4%
Changes in cash and cash equivalents –14.1 –33.5 –57.9%
Oktober 2015
In accordance with IFRS 11 (at equity)
Capital expenditure 2014/2015 Strengthening of growth markets
October 2015
* incl. potato
Investor Presentation 18
By region
Germany 24%
Americas
25%
43% Europe
(w/o Germany)
Rest of world 8%
Capital expenditure
€ 140.6 mn
By business segment
37% Corn 17%
Sugarbeet*
32% Cereals
Corporate 14%
Capital expenditure
€ 140.6 mn
Segment report
Corn Segment
Corn acreage for sowing season 2015
October 2015 Investor Presentation 21
0.8 1.6 2.1 2.6 3.0 3.7
4.9
7.8
15.5
36.0 37.8
NorthernEurope
CentralEurope
SouthernEurope
Germany France Argentinia South EastEurope
EasternEurope
Brazil NorthAmerica
China
Market volume 2014/2015* (in mn ha)
EU 28: 13.6 mn ha (–3%)
Europa (excl. CH, incl. TR, UA, RU): 22.4 mn ha (–4%)
NE: DK, UK, NL, BE; SOE: HU, BG, AT, RO, RS, HR; NA: US; ME: PL, CZ, SK; SE: IT, ES, PT; OE: RU, UA
* Priliminary data Source: Kleffmann; KWS; USDA; Statistical Office of China; Brazilian Department of Agriculture
Corn EU Sales development and market share
October 2015 Investor Presentation 22
259
297 314 324 321
10/11 11/12 12/13 13/14 14/15
Syngenta 6%
Net sales* in € mn
CAGR
5.5%
Market share* 2014/2015
19% KWS
Vilmorin 14%
Others 24%
22% Pioneer
15% Monsanto
EU acreage
13.6 mn ha
* Preliminary data; Source: Kleffmann; own estimates KWS * Including sales with oilseeds & catch crops
Corn North America Sales development and market share
October 2015 Investor Presentation 23
50:50-JV with Vilmorin, France
358
451
537 509
556
10/11 11/12 12/13 13/14 14/15
CAGR
11.6%
Syngenta 5%
*Preliminary data, KWS
7% AgReliant
Dow 5%
Others 16%
33% Pioneer
Monsanto 34%
US acreage
36.0 mn ha
Net sales* in € mn
Market share* 2014/2015
* Including sales with oilseeds & catch crops
Corn other regions Sales development
October 2015 Investor Presentation 24
39 50
123 145 155
10/11 11/12 12/13 13/14 14/15
CAGR
41.2%
53% South Americas
30% European
non EU states
Asia/Africa 17%
Sales
€ 155 mn
Net sales* in € mn
Sales breakdown 2014/2015
* Including sales with oilseeds & catch crops
Sugarbeet Segment
Sugarbeet segment sales
October 2015
Total segment sales
Potato 9%
91% Sugarbeet
Segment sales
2014/2015
€390.5 mn
Investor Presentation 26
Sugarbeet worldwide Sales development and market share
October 2015 Investor Presentation 27
1 Sugarbeet seeds w/o potato
Net sales1 in € mn
267 281
298 319
364
10/11 11/12 12/13 13/14 14/15
CAGR
8.1%
Global acreage: 4.0 mn ha (–4%)
26% KWS
17% SESVanderHave
16% Betaseed
Strube 11%
Desprez 5%
Crystal 12%
2% Others
Market share1,2
2014/2015
Syngenta 8%
2 Own data KWS, 2015
1 Sugarbeet seeds w/o potato
Maribo 3%
Sugarbeet EU Sales development and market share
October 2015
2 Own data KWS, 2014
1 Sugarbeet seeds w/o potato
Investor Presentation 28
132 129 128 137 136
10/11 11/12 12/13 13/14 14/15
CAGR
0.8%
Net sales1 in € mn
EU-acreage 2015: 1.4 mn ha (–14%)
20% SESVanderHave
Maribo 4%
Strube 18%
Syngenta 6%
Desprez 4%
Betaseed 5%
2% Others
Market share1,2
2014/2015
41% KWS
1 Sugarbeet seeds w/o potato
EU sugar market regime 2017
October 2015 Investor Presentation 29
Acreage expected to stay stable
Slight acreage expansion in competitive countries
Slight acreage reduction due to step-wise increase of isoglucose production
Higher sugar price volatility leads to higher acreage fluctuation
EU border protection is obtained
What lies ahead? – New research & breeding projects: New breeding technologies (GABI)
KWS & Bayer CONVISO® SMART (non-GMO herbicide resistance)
KWS & BASF Yield genes (GMO)
Rizomania resistance (GMO virus resistance)
…
Important sugarbeet research projects at KWS
October 2015
KWS will remain no. 1 in innovations
Investor Presentation 30
Cereals Segment
KWS cereals activities
October 2015
Acreage-related decline in hybrid rye business
Investor Presentation 32
78 93
112 107 111
10/11 11/12 12/13 13/14 14/15
CAGR
9.2%
Net sales in € mn
Wheat 21%
Barley 20%
Others 6%
Rapeseed 10%
Net sales breakdown by product group
43% Rye
Segment sales
2014/2015
€ 111.3 mn
KWS cereals activities
October 2015
Takeover of the remaining 51% of shares in MOMONT, France
Investor Presentation 33
Research & Development
Research & development at KWS Base of a successful Corporate Development
October 2015 Investor Presentation 35
R&D expenditure in € mn
114
127
140 150
174
0
50
100
150
200
10/11 11/12 12/13 13/14 14/15
CAGR
11.2%
13.3% 12.9% 12.2% 12.7% 13.8%
10/11 11/12 12/13 13/14 14/15
R&D intensity
Research & development at KWS Highly innovative and tailor-made
October 2015 Investor Presentation 36
296 303 276
336
429
10/11 11/12 12/13 13/14 14/15
1,446
1,460
1,582 1,768
1,836
10/11 11/12 12/13 13/14 14/15
R&D employees Marketing approvals for new varieties
KWS: Global breeding
October 2015 Investor Presentation 37
Breeding and distribution in over 70 countries
Breeding stations
Trial locations
Genetically engineered trait Lead gene
identification
Proof of
concept
Elite Event
selection
Deregulation
Commerciali-
zation
Glyphosate tolerance
Virus resistance
Yield genes
Glyphosate tolerance
Glyphosate tolerance
+ Insect resistance
Drought tolerance
Nitrogen use efficiency
Fungal resistance
Fungal resistance
KWS trait pipeline Progress by project
October 2015 Investor Presentation 38
Corn traits from different companies
October 2015 Investor Presentation 39
Trait Event Event name Monsanto Syngenta DuPont/Pioneer DOW
Subterranean
insect pests
MON88017 YieldGard VT
Rootworm D X
MIR604 Agrisure RW D X
5307 Agrisure Duracade D
59122 Hercules RW,
AcerMax RW X X D D
MON87411 RNAi+Cry3Bb1 D X
Aerial insect
pests
MON810 YieldGard D X
Bt11 Agrisure TL,
Agrisure CB/LL D
TC1507 Herculex I,
Herculex CB X D D
MON89034 YieldGard VT
(Double) Pro D X X
MIR162 Agrisure Viptera X D X
Herbicide
tolerance
GA21 Agrisure GT D
NK603 Roundup Ready 2 D X X
T25 Liberty Link X X X X
DAS-4Ø278-9 Enlist X D
D = Developer (2 „Ds“ in one row = joint development) X= Licensee
Employees
October 2015 Investor Presentation 40
2014/2015 2013/2014 +/–
Research & development 1,985 1,836 8.1%
Distribution 1,259 1,241 1.5%
Production 1,408 1,136 23.9%
Administration 670 634 5.7%
Total 5,322 4,847 9.8%
Employees by function*
35% Americas
Others 4%
26% Europe
(w/o Germany)
Employees by region*
35% Germany
*On average for the year
Forecast 2014/2015 KWS Group in accordance with IFRS 11
Forecast 2015/2016
October 2015 Investor Presentation 42
KWS Group Sales EBIT margin R&D intensity
2015/2016 1,035 – 1,085 > 10.5% ~17%
Forecast for the KWS Group in accordance with IFRS 11
Forecast 2015/2016 Segment report
Forecast 2015/2016
October 2015 Investor Presentation 44
2015/2016 2014/2015
Sales +10% to 15% € 754.4 mn
EBIT margin around 11% 11.2%
Corn
2015/2016 2014/2015
Sales
at the level of the
previous year
€ 390.5 mn
EBIT margin
at the level of the
previous year
23.8%
Sugarbeet
2015/2016 2014/2015
Sales slight growth € 111.3 mn
EBIT margin below previous year 10.8%
Cereals
2015/2016 2014/2015
Sales stable € 4.2 mn
EBIT around –60 Mio. € € –51.2 mn
Corporate
Appendix
Principles
46
1. We optimize genetic potential through excellent research
and breeding programs.
2. We deliver best-quality seeds to our farmers.
3. We act as trusted performance partners for our farmers
throughout their value chain.
4. In order to support talents at all levels to perform, we
provide for entrepreneurial freedom.
Mission
KWS seeds the future.
Our high-performing seeds and thorough knowledge of
agriculture make us the trusted supplier for generations of
farmers. This is our contribution in addressing growing global
food demand.
Vision
October 2015 Investor Presentation
The Executive Board
October 2015
Dr. Hagen Duenbostel (1970)
CEO/Member of the
Executive Board since 2003
Responsibility: Corn, Development
& Communication, Compliance
Degree in Business Administration;
Dr. rer. pol.
Dr. Léon Broers (1960)
Member of the
Executive Board since 2007
Responsibility: Research, Breeding
Ph.D. in Plant Breeding;
Master of Business Administration
Dr. Peter Hofmann (1960)
Member of the
Executive Board since 2014
Responsibility: Sugarbeet, Cereals,
Marketing
Degree in Agronomy;
Ph.D. in Seed Physiology
Eva Kienle (1967)
Member of the
Executive Board since 2013
Responsibility: Finance, Law,
Procurement, Controlling, IT, HR,
Global Services, Investor Relations
Degree in Business Administration
Investor Presentation 47
The KWS share
October 2015
Shareholder structure
No. of shares:
6,600,000
56.0% Families
Büchting
Arend Oetker
Giesecke
15.1% Tessner Beteiligungs
GmbH
Free float 28.9%
Key figures per October 8, 2015 (Xetra)
Closing call: €301.00
Market Cap.: €1.99 bn
Free Float Market Cap.: €572 mn
52 weeks high/low: €313.55/€257.00
WKN: 707400
ISIN: DE0007074007
Symbol: KWS
Investor Presentation 48
Financial calendar & IR contact
October 2015 Investor Presentation 49
Date
November 24, 2015 Report on the 1st quarter of 2015/2016
December 17, 2015 Annual Shareholders’ Meeting in Einbeck
February 25, 2016 Report on the 2nd quarter of 2015/2016
May 26, 2016 Report on the 3rd quarter of 2015/2016
October 25, 2016 Publication of 2015/2016 financial statements, annual press and analyst conference in Frankfurt
December 15, 2016 Annual Shareholders’ Meeting in Einbeck
Financial calendar
Wolf-Gebhard von der Wense Head of Investor Relations
+49 (0) 5561 311-968
KWS SAAT SE
Grimsehlstr. 31
37574 Einbeck
Lisa Bertram Investor Relations
+49 (0) 5561 311-14 97
KWS SAAT SE
Grimsehlstr. 31
37574 Einbeck
Disclaimer
October 2015
These materials are not an offer for sale of Subscription rights or Securities in the United States. Subscription rights and Securities may not be
offered or sold in the United States without registration or an exemption from registration under the U.S Securities Act of 1993, as amended.
KWS SAAT SE does not intend to register any portion of the offering in the United States or to conduct a public offering in the United States or to
conduct a public offering of Subscription rights or Securities in the United States.
This document contains certain forward-looking statements relating to the business, financial performance and results of KWS SAAT SE and/or
its subsidiaries and/or the industry in which KWS SAAT SE and its subsidiaries operate. These forward-looking statements are based on KWS’
current plans, estimates, projections and expectations. These statements are based on certain assumptions that, although reasonable at this
time, may prove to be erroneous. Prospective investors should not place undue reliance on these forward-looking statements.
If certain risks and uncertainties materialize, or if certain underlying assumptions prove incorrect, events described in this document as
anticipated, believed, estimated or expected may not occur, and KWS SAAT SE may not be able to achieve its financial targets and strategic
objectives. This presentation should not be viewed as definitive legal, tax, or other advice regarding investment. All interested investors should
seek independent third party legal, tax, and other advice.
KWS SAAT SE does not intend, and does not assume any obligations, to update industry information or forward-looking statements set forth in
this document. KWS SAAT SE assumes no responsibility or liability in regard to the completeness of the contents and the accuracy of opinions,
estimates, prognoses, calculations, or other information contained in this presentation. This presentation may contain confidential information.
Neither the presentation nor any of its contents may be reproduced or otherwise made available to third parties.
Investor Presentation 50